Per-Ola Önnervik

Per-Ola has over twenty years of experience of drug discovery with the main focus on in vivo pharmacology. The main disease areas have been respiratory diseases and rheumatoid arthritis. At Astra Zeneca R&D Lund Per-Ola lead the set up and co-ordination of major global collaborations with world leading academic groups in the area of COPD. In addition, Per-Ola has several years of experience from line management and senior scientific roles within discovery organizations before he took on a role in the clinical organization where the lead clinical trials. In 2012 Per-Ola joined Truly Translational as Principal Scientist. Since 2015 Per-Ola holds a position as Head of In Vivo Biology at Truly Labs AB.